Dr. Thomas Cannell, President and CEO of Sesen Bio, to Host Conference Call to Provide Business Update Highlighting Regulatory Progress and Commercial Opportunity for Vicinium® By Andrew Clark, 25th February 2020
Sesen Bio Announces Changes to the Board of Directors as the Company Advances Toward Commercialization of Vicinium® By Andrew Clark, 24th February 2020
